B.Riley Financial Maintains X4 Pharmaceuticals(XFOR.US) With Hold Rating, Cuts Target Price to $0.5

Futu NewsNov 19 16:36 · Ratings

B. Riley Adjusts X4 Pharmaceuticals Price Target to $0.50 From $1, Maintains Neutral Rating

MT NewswiresNov 18 22:01 · Ratings

X4 Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 15 02:19 · Ratings

Stifel Maintains Buy on X4 Pharmaceuticals, Lowers Price Target to $4

BenzingaNov 14 17:52 · Ratings

X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference

X4 PharmicalsNov 14 13:00

Express News | X4 Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $2 From $3

BreakingsNov 14 12:34